| CLRB Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CLRB shares outstanding history going back to 3/7/2016:
Also see: CLRB Market Cap History CLRB YTD Return |
CLRB Shares Outstanding History — Cellectar Biosciences Share Count Over Time
As of 2/24/2026 Cellectar Biosciences has 4.24 million CLRB shares outstanding. Investors often track the CLRB shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CLRB share count trends over time, with 44 historical shares outstanding datapoints presented, dating back to 3/7/2016.
| CLRB Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CLRB Historical Shares Outstanding: +161.90% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CLRB Stock Price Chart |
| About Cellectar Biosciences Inc |
| Cellectar Biosciences, Inc. is a late-stage clinical biopharmaceutical company. Co. is focused on the discovery, development and commercialization of drugs for the treatment of cancer. Co., through phospholipid ether drug conjugate (PDC) delivery platform, is focused on developing PDCs that are designed to specifically target cancer cells. Its PDC platform possesses the potential for the discovery and development of cancer-targeting treatments, and it plans to develop PDCs both independently and through research and development collaborations. We show 44 historical shares outstanding datapoints in our coverage of CLRB's shares outstanding history. Understanding the changing numbers of CLRB shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CLRB versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CLRB by allowing them to research CLRB shares outstanding history as well as any other stock in our coverage universe. |
| CLRB Current Stock Quote |
Quotes delayed 20 minutes  Free CLRB Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CLRB Share Performance |
| Shares Outstanding Peers |
| Cellectar Biosciences (CLRB) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CLSD Shares Outstanding History CLSN Shares Outstanding History CLVS Shares Outstanding History CLXT Shares Outstanding History CLYM Shares Outstanding History CMAX Shares Outstanding History CMD Shares Outstanding History CMPI Shares Outstanding History CMPX Shares Outstanding History CMRA Shares Outstanding History More Healthcare companies » |
CLRB Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
